Urografin 76 per cent2 has a low toxicity and is usually suitable for angiocardiographic examinations. Its relatively high viscosity, however, makes it less suitable as a contrast medium in cases in which only small catheters can be used and in those in which a low injection pressure is desirable. A new preparation, Urovison,3 contains mainly sodium amidotrizoate and has a considerably lower viscosity than Urografin 76 per cent. Since there is need for a less viscous medium and since the use of Urovison in angiocardiography had been reported with favorable results (Weissleder and Kiefer, 1966), it was thought of interest to compare some of the side-effects of Urografin 76 per cent with those of Urovison in patients. The electrocardiographic changes following angiocardiography with Urografin 76 per cent were studied, as were those when Urovison was the contrast medium. In addition, the subjective side-effects were compared. In questioning the patients for their side-effects, care was taken not to influence the answers. In 10 nonselected cardiac patients identical injections of Urografin 76 per cent and Urovison were made as part of a routine preoperative study. In 5 patients the injections were made in the left ventricle through a transseptal catheter or through a catheter introduced retrograde from the femoral artery, and in 5 the injections were made in the ascending aorta with a percutaneously introduced catheter. Every second time Urografin 76 per cent was injected first and every second time Urovison. The patient and the tip of the catheter remained in the same position for both injections. Similar quantities of the two contrast media were employed, and the pressure in the injector was adjusted so that the speed of the injection was similar with both contrast media. An interval of fifteen minutes between the injections permitted heart rate and blood pressure to return to normal before the second injection. Biplane angiocardiography or cineangiocardiography was performed. The roentgen exposures, the electrocardiogram (lead 2), the arterial pressure, and usually one intracardiac pressure were recorded before, during, and after the injections. The recording was usually stopped one minute after the injection, but when electrocardiographic changes persisted, the recordings lasted longer. The electrocardiographic changes in heart rate were recorded, as were the occurrence of extrasystole and changes in the S-T interval or in the T-wave. Results The diagnostic value of the angiocardiograms or cineangiocardiograms obtained with the two different media was similar. Changes in Heart Rate: With both contrast media, a moderate bradycardia was followed by a slight tachycardia in all patients. There was no obvious difference between the two agents in this respect. Extrasystole occurred in 3 patients after injection of Urovison, whereas similar injections of Urografin 76 per cent gave no extrasystole.
Read full abstract